Company
Aptinyx
Claim, correct or request removal
Record updated 28 September 2026
About
Aptinyx is developing a new class of pharmaceuticals treating peripheral nerve pain. The company completed an IPO in June 2018 and trades under the symbol APTX.
Loading relationship preview